DLHCX:NASDAQ
Macquarie Healthcare Fund Class C – DLHCX Fund Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| 20.72 | -0.23 (-1.10%) | 20.67 - 27.30 | -- |
Market data as of 12:00AM 04/03/25. Quotes are delayed by at least 15 min.
Overview - DLHCX
The investment seeks maximum long-term capital growth through capital appreciation.
Under normal circumstances, the fund will invest at least 80% of its assets, plus the amount of any borrowings for investment purposes, in the equity securities of healthcare companies, meaning companies that develop, produce, or distribute products or services related to the healthcare or medical industries and derive a substantial portion, that is, more than 50%, of their sales from products and services in the healthcare industry (80% policy). It is non-diversified.
Growth of $10,000 (10 Years)
| Total Return | 12.05% |
|---|
| Yield (Trailing 12 Mo.) | 0.00% |
|---|
| Expense Ratio | 2.00% |
|---|
| Front Load | None |
|---|
| Deferred Load | 1.00% |
|---|
| Minimum Investment | $1,000 |
|---|
| Management Tenure | 17 Years |
|---|
| Fund Inception | 01/28/2010 |
|---|
Trailing Total Returns - DLHCX
as of 02/28/2025
| Timeframe | DLHCX | S&P 500 | Health |
|---|
| 1 Month | 0.69% | -5.63% | -5.16% |
|---|
| 3 Month | 0.20% | -4.27% | -1.46% |
|---|
| Year-to-Date | 4.91% | -4.27% | -1.46% |
|---|
| 1 Year | 3.74% | 8.25% | -6.28% |
|---|
| 3 Year | 6.91% | 9.06% | -1.28% |
|---|
| 5 Year | 7.66% | 18.59% | 6.84% |
|---|
| 10 Year | 8.26% | 12.50% | 5.31% |
|---|
| Since Inception | 12.05% | 10.98% | -- |
|---|
Sector Allocation - DLHCX
as of 02/28/2025
| Basic Materials | | 0.12% |
|---|
| Consumer Cyclical | | 0.00% |
|---|
| Financial Services | | 1.72% |
|---|
| Real Estate | | 0.00% |
|---|
| Consumer Defensive | | 0.54% |
|---|
| Healthcare | | 96.90% |
|---|
| Utilities | | 0.00% |
|---|
| Communication Services | | 0.67% |
|---|
| Energy | | 0.00% |
|---|
| Industrials | | 0.00% |
|---|
| Technology | | 0.04% |
|---|
Asset Allocation - DLHCX
as of 02/28/2025
| By Percent | Short | 0% | Long | Net |
|---|
| Stock | -- | | | 80.87 | 80.87 |
|---|
| Bond | -- | | | 0.00 | 0.00 |
|---|
| Other | -- | | | 0.00 | 0.00 |
|---|
| Foreign Stock | -- | | | 18.63 | 18.63 |
|---|
| Foreign Bond | -- | | | 0.00 | 0.00 |
|---|
| Total | -- | | | 99.50 | 99.50 |
|---|
| Cash | -- | | | 0.50 | 0.50 |
|---|
| Total Net Assets | $738.27M |
|---|
| Total Stock Holdings | 103 |
|---|
| Total Bond Holdings | 0 |
|---|
Top Ten Holdings - DLHCX
as of 02/28/2025
| Company | YTD Return | % of Assets |
|---|
| LLY | -- | 9.50% |
|---|
| BSX | -- | 5.35% |
|---|
| UNH | -- | 4.90% |
|---|
| REGN | -- | 4.46% |
|---|
| MRK | -- | 4.17% |
|---|
| PFE | -- | 4.11% |
|---|
| Chugai Pharmaceutical Co Ltd | -- | 3.96% |
|---|
| ABBV | -- | 3.69% |
|---|
| AMGN | -- | 3.66% |
|---|
| Roche Holding AG | -- | 3.62% |
|---|
Valuation & Growth - DLHCX
as of 02/28/2025
| Valuation | DLHCX | Category Range |
|---|
| Price/Earnings | 26.99 | |
|---|
| Price/Book | 3.36 | |
|---|
| Price/Sales | 2.65 | |
|---|
| Price/Cash Flow | 19.03 | |
|---|
| Dividend Yield | 1.7 | |
|---|
| LT Earnings | 14.67 | |
|---|
| Historical Earnings | -1.72 | |
|---|
| Sales Growth | 3.07 | |
|---|
| Cash-Flow Growth | -14.98 | |
|---|
| Book-Value Growth | 0.02 | |
|---|
